BIO-key International Inc. (NASDAQ:BKYI) does about 7.61M shares in volume on a normal day but saw 3493976 shares change hands in Tuesday trading. The company now has a market cap of 31.97M USD. Its current market price is $0.55, marking a decrease of -4.35% compared to the previous close of $0.57. The 52 week high reached by this stock is $2.58 whilst the lowest price level in 52 weeks is $0.35. The script in recent trading has seen the stock touch a high of $0.58 and a low of $0.535.
BIO-key International Inc. (BKYI) has a 20-day trading average at $0.6962 and the current price is -78.68% off the 52-week high compared with 57.14% distance from its 52-week low. The 50-day simple moving average of the closing price is $0.7433 and its 200-day simple moving average is $0.7126. If we look at the stock’s price movements over the week, volatility stands at 8.10%, which increases to 8.25% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 35.06 to suggest the stock is neutral.
1 analysts observing the BIO-key International Inc. (BKYI) stock have set the 12-month price targets for the company’s shares at between $2.00 and $2.00. The median price target is 72.5% away from the current levels at $2.00.
FactSet Research has provided data showing that 1 brokerages have issued ratings for the stock. 0 analysts have rated it as a sell, while 0 advise that it is a overweight. 0 analysts have rated it as a buy and 1 have advised that investors hold their positions. The consensus recommendation rating is Hold and Wall Street’s advice is for investors to Hold the stock.
The current price level is -21.87%, -26.51%, and -22.80% away from its SMA20, SMA50, and SMA200 respectively, with the BKYI price moving above the 50-day SMA on September 01. BIO-key International Inc. (BKYI) stock is down -15.61% over the week and -22.18% over the past month. Its price is 10.00% year-to-date and -21.43% over the past year.
The stock last released its quarterly earnings report for quarter ended 6/29/2020, with the company’s earnings per share (EPS) of -$0.07 below consensus estimates by -$0.04. The company’s next earnings report is expected on 11/11/2020, with forecasts estimating quarterly EPS at -$0.01 and -$0.15 for whole year. BKYI’s earnings per share are forecast to grow by 63.40% this year and 93.30% over next year. Expected sales for next quarter are $1.35 million, which analysts say will come at $3.09 million for the current fiscal year and next year at $7.49 million. In addition, estimates put the company’s current quarterly revenue at an average of $910k.
Its 12-month price target is $2.00. Of course, the average price target is just what the average analysts believe a stock will be worth in the next 52 weeks, and is only one metric. There are analysts with lower targets than the average, including one bearish Wall Street research firm advocating investors to wait for the price to pull back to $2.00, given the recent momentum. And then, on the bullish side of things, one analyst is expecting the stock to peak at $2.00.
Outstanding shares total 56.30M with insiders holding 58.16% of the shares and institutional holders owning 0.77% of the company’s common stock. The beta has a value of 1.03. Price to book ratio is 13.75 and price to sales ratio is 17.76.
According to a U.S. Securities and Exchange Commission filing, Vanguard Extended Market Index Fu has reduced its position in BIO-key International Inc. (BKYI) to 78,056 shares, mirroring a recent drop by 0.00%. Vanguard Extended Market Index Fu dumped 0.0 shares of BIO-key International Inc. common stock bringing its total worth to about $54561.0 at the end of recent close, SEC documents show.